Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in ACADIA PHARMACEUTICALS INC
BNP PARIBAS FINANCIAL MARKETS holds 44,756 shares of ACAD (ACADIA PHARMACEUTICALS INC), worth $1.2M as of 2025-Q4. The position was decreased (-19.4% shares). ACAD represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$1.2M
Current Shares
44,756
Total Value Change
+$183,269
Total Shares Change
-17,531
Other major holders of ACAD: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 44,756 |
-19.4% |
| $1.2M |
| 0.0% |
| $26.70 |
0 |
| 2025-Q3 | Decreased | 55,548 | -27.6% | $1.2M | 0.0% | $21.32 | 0 |
| 2025-Q2 | Decreased | 76,754 | -67.7% | $1.7M | 0.0% | $22.12 | 0 |
| 2025-Q1 | Decreased | 237,410 | -17.7% | $3.9M | 0.0% | $17.07 | 0 |
| 2024-Q4 | Increased | 288,471 | +29.0% | $5.3M | 0.0% | $16.69 | 34 |
| 2024-Q3 | Increased | 223,618 | +259.0% | $3.4M | 0.0% | $15.69 | 43 |
| 2024-Q2 | Decreased | 62,287 | -48.2% | $1M | 0.0% | $16.25 | 0 |